Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS
· Delayed Price · Currency is USD
0.0072
0.00 (0.00%)
At close: Apr 29, 2026
Petros Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 5.14 | 1.72 | 13.34 | 9.43 | 23.85 | Upgrade
|
| Cash & Short-Term Investments | 5.14 | 1.72 | 13.34 | 9.43 | 23.85 | Upgrade
|
| Cash Growth | 198.88% | -87.11% | 41.49% | -60.47% | 39.14% | Upgrade
|
| Accounts Receivable | - | - | 2.23 | 2.11 | 2.46 | Upgrade
|
| Other Receivables | - | - | - | - | 0.61 | Upgrade
|
| Receivables | - | - | 2.23 | 2.11 | 3.06 | Upgrade
|
| Inventory | - | - | 2.79 | 1.82 | 0.52 | Upgrade
|
| Prepaid Expenses | 0.03 | 0 | 1.22 | 0.51 | 1.58 | Upgrade
|
| Other Current Assets | - | 5.57 | 0.82 | 0.8 | 1.53 | Upgrade
|
| Total Current Assets | 5.16 | 7.29 | 20.39 | 14.67 | 30.54 | Upgrade
|
| Property, Plant & Equipment | - | - | 0.26 | 0.4 | 0.52 | Upgrade
|
| Other Intangible Assets | - | - | 8.97 | 12.24 | 25.29 | Upgrade
|
| Other Long-Term Assets | - | 3.34 | 4.18 | 5.11 | 11.03 | Upgrade
|
| Total Assets | 5.16 | 10.64 | 33.8 | 32.42 | 67.39 | Upgrade
|
| Accounts Payable | 0.08 | 0.76 | 1.71 | 1.81 | 4.56 | Upgrade
|
| Accrued Expenses | 0.14 | 0.1 | 1.18 | 1.32 | 3.5 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 1.16 | 1.09 | - | Upgrade
|
| Current Portion of Leases | - | - | 0.13 | 0.14 | 0.13 | Upgrade
|
| Other Current Liabilities | 2.07 | 17.16 | 6.59 | 2.71 | 22.8 | Upgrade
|
| Total Current Liabilities | 2.29 | 18.03 | 10.77 | 7.07 | 30.98 | Upgrade
|
| Long-Term Debt | - | - | 6.86 | 8.39 | - | Upgrade
|
| Long-Term Leases | - | - | 0.14 | 0.26 | 0.41 | Upgrade
|
| Other Long-Term Liabilities | - | 0.08 | 3.55 | 0 | 0.46 | Upgrade
|
| Total Liabilities | 2.29 | 18.1 | 21.32 | 15.72 | 31.85 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 114.16 | 105.74 | 110.96 | 107.43 | 106.23 | Upgrade
|
| Retained Earnings | -111.29 | -113.21 | -98.89 | -90.73 | -70.69 | Upgrade
|
| Total Common Equity | 2.87 | -7.47 | 12.07 | 16.7 | 35.54 | Upgrade
|
| Shareholders' Equity | 2.87 | -7.47 | 12.48 | 16.7 | 35.54 | Upgrade
|
| Total Liabilities & Equity | 5.16 | 10.64 | 33.8 | 32.42 | 67.39 | Upgrade
|
| Total Debt | - | - | 8.28 | 9.88 | 0.53 | Upgrade
|
| Net Cash (Debt) | 5.14 | 1.72 | 5.06 | -0.46 | 23.32 | Upgrade
|
| Net Cash Growth | 198.88% | -66.04% | - | - | 150.05% | Upgrade
|
| Net Cash Per Share | 0.18 | 5.35 | 58.14 | -5.51 | 535.30 | Upgrade
|
| Filing Date Shares Outstanding | 42.37 | 2.14 | 0.28 | 0.08 | 0.08 | Upgrade
|
| Total Common Shares Outstanding | 42.28 | 0.42 | 0.12 | 0.08 | 0.08 | Upgrade
|
| Working Capital | 2.87 | -10.73 | 9.62 | 7.6 | -0.44 | Upgrade
|
| Book Value Per Share | 0.07 | -17.73 | 100.88 | 200.81 | 429.60 | Upgrade
|
| Tangible Book Value | 2.87 | -7.47 | 3.1 | 4.46 | 10.25 | Upgrade
|
| Tangible Book Value Per Share | 0.07 | -17.73 | 25.90 | 53.60 | 123.91 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.